Center for Disease Control and
Prevention (CDC). Interim Guidance for a Public Health Response to Contain
Novel or Targeted Multidrug-resistant Organisms (MDROs) Atlanta, GA:
Center for Disease Control and Prevention (CDC); January 2019.
Siegel JD, Rhinehart E, Jackson
M, Chiarello L. Management of multidrug-resistant organisms in healthcare
settings, 2006. Atlanta, GA: Center for Disease Control and Prevention
(CDC); 2006.
Chan M. Ten Years in Public
Health, 2007–2017: A Global Health Guardian: Climate Change, Air Pollution
and Antimicrobial Resistance. Geneva: World Health Organization (WHO);
2017.
Palmore TN, Henderson DK.
Managing transmission of carbapenem-resistant Enterobacteriaceae in healthcare
settings: A view from the trenches. Clin Infect Dis. 2013;57(11):1593–9.
Trick WE, Lin MY, Cheng-Leidig
R, et al. Electronic public health registry of extensively drug-resistant
organisms, Illinois, USA. Emerg Infect Dis. 2015;21(10):1725–32.
Center for Disease Control and
Prevention (CDC). Containing Unusual Resistance. CDC Vital Signs. Atlanta,
GA: April 2018.
Tacconelli E, Cataldo MA, Dancer SJ, et al. ESCMID
guidelines for the management of the infection control measures to reduce
transmission of multidrug-resistant Gram-negative bacteria in hospitalized
patients. Clin Microbiol Infect. 2014;20: Suppl 1:1–55.
Kourtis AP, Hatfield K, Baggs
J, et al. Vital signs: Epidemiology and recent trends in
methicillin-resistant and in methicillin-susceptible Staphylococcus aureus
bloodstream infections - United States. MMWR Morb Mortal Wkly Rep.
2019;68(9):214–9.
Yokoe DS, Anderson DJ,
Berenholtz SM, et al. A compendium of strategies to prevent
healthcare-associated infections in acute care hospitals: 2014 updates.
Infect Control Hosp Epidemiol. 2014;35(8):967–77.
Calfee DP, Salgado CD, Milstone
AM, et al. Strategies to prevent methicillin-resistant Staphylococcus
aureus transmission and infection in acute care hospitals: 2014 update.
Infect Control Hosp Epidemiol. 2014;35(7):772–96.